Cargando…
Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma
Background: Radiofrequency ablation (RFA) is a curative modality for hepatocellular carcinoma (HCC) patients who are not suitable for resection. It remains controversial whether a surgical or percutaneous approach is more appropriate for HCC. Method: A search was performed on the PubMed, Web of Scie...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763842/ https://www.ncbi.nlm.nih.gov/pubmed/35059430 http://dx.doi.org/10.3389/fsurg.2021.788771 |
_version_ | 1784634039495294976 |
---|---|
author | Huang, Xiaozhun Liu, Yibin Xu, Lin Ma, Teng Yin, Xin Huang, Zhangkan Wang, Caibin Huang, Zhen Bi, Xinyu Che, Xu |
author_facet | Huang, Xiaozhun Liu, Yibin Xu, Lin Ma, Teng Yin, Xin Huang, Zhangkan Wang, Caibin Huang, Zhen Bi, Xinyu Che, Xu |
author_sort | Huang, Xiaozhun |
collection | PubMed |
description | Background: Radiofrequency ablation (RFA) is a curative modality for hepatocellular carcinoma (HCC) patients who are not suitable for resection. It remains controversial whether a surgical or percutaneous approach is more appropriate for HCC. Method: A search was performed on the PubMed, Web of Science, Embase, and Cochrane Library databases from the date of database inception until April 17, 2021. Studies reporting outcomes of comparisons between surgical RFA (SRFA) and percutaneous RFA (PRFA) were included in this study. The meta-analysis was performed using the Review Manager 5.3 and Stata 12.0 software. Result: A total of 10 retrospective studies containing 12 cohorts, involving 740 patients in the PRFA group and 512 patients in the SRFA group, were selected. Although the tumor size in PRFA group was smaller than the SRFA group (p = 0.007), there was no significant difference in complete ablation rate between the SRFA and PRFA groups (95.63% and 97.33%, respectively; Odds ratio [OR], 0.56; 95% confidence intervals [CI], 0.26–1.24; p = 0.15). However, the SRFA group showed a significantly lower local tumor recurrence than the PRFA group in the sensitivity analysis (28.7% in the PRFA group and 21.79% in the SRFA group, respectively; OR, 1.84; 95% CI, 1.14–2.95; p = 0.01). Pooled analysis data showed that the rate of severe perioperative complications did not differ significantly between the PRFA and SRFA groups (14.28% and 12.11%, respectively; OR, 1.30; 95% CI, 0.67-2.53; p = 0.44). There was no significant difference in the 1-, 3-, and 5-year overall survival rates, as well as the 1- and 3-year disease-free survival (DFS) between the PRFA and SRFA groups. The 5-year DFS of the PRFA group was significantly lower than the SRFA group (hazard ratio 0.73; 95% CI 0.54–0.99). Conclusion: Based on our meta-analysis, the surgical route was superior to PRFA in terms of local control rate. Furthermore, the surgical approach did not increase the risk of major complications. |
format | Online Article Text |
id | pubmed-8763842 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87638422022-01-19 Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma Huang, Xiaozhun Liu, Yibin Xu, Lin Ma, Teng Yin, Xin Huang, Zhangkan Wang, Caibin Huang, Zhen Bi, Xinyu Che, Xu Front Surg Surgery Background: Radiofrequency ablation (RFA) is a curative modality for hepatocellular carcinoma (HCC) patients who are not suitable for resection. It remains controversial whether a surgical or percutaneous approach is more appropriate for HCC. Method: A search was performed on the PubMed, Web of Science, Embase, and Cochrane Library databases from the date of database inception until April 17, 2021. Studies reporting outcomes of comparisons between surgical RFA (SRFA) and percutaneous RFA (PRFA) were included in this study. The meta-analysis was performed using the Review Manager 5.3 and Stata 12.0 software. Result: A total of 10 retrospective studies containing 12 cohorts, involving 740 patients in the PRFA group and 512 patients in the SRFA group, were selected. Although the tumor size in PRFA group was smaller than the SRFA group (p = 0.007), there was no significant difference in complete ablation rate between the SRFA and PRFA groups (95.63% and 97.33%, respectively; Odds ratio [OR], 0.56; 95% confidence intervals [CI], 0.26–1.24; p = 0.15). However, the SRFA group showed a significantly lower local tumor recurrence than the PRFA group in the sensitivity analysis (28.7% in the PRFA group and 21.79% in the SRFA group, respectively; OR, 1.84; 95% CI, 1.14–2.95; p = 0.01). Pooled analysis data showed that the rate of severe perioperative complications did not differ significantly between the PRFA and SRFA groups (14.28% and 12.11%, respectively; OR, 1.30; 95% CI, 0.67-2.53; p = 0.44). There was no significant difference in the 1-, 3-, and 5-year overall survival rates, as well as the 1- and 3-year disease-free survival (DFS) between the PRFA and SRFA groups. The 5-year DFS of the PRFA group was significantly lower than the SRFA group (hazard ratio 0.73; 95% CI 0.54–0.99). Conclusion: Based on our meta-analysis, the surgical route was superior to PRFA in terms of local control rate. Furthermore, the surgical approach did not increase the risk of major complications. Frontiers Media S.A. 2022-01-04 /pmc/articles/PMC8763842/ /pubmed/35059430 http://dx.doi.org/10.3389/fsurg.2021.788771 Text en Copyright © 2022 Huang, Liu, Xu, Ma, Yin, Huang, Wang, Huang, Bi and Che. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Surgery Huang, Xiaozhun Liu, Yibin Xu, Lin Ma, Teng Yin, Xin Huang, Zhangkan Wang, Caibin Huang, Zhen Bi, Xinyu Che, Xu Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma |
title | Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma |
title_full | Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma |
title_fullStr | Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma |
title_full_unstemmed | Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma |
title_short | Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma |
title_sort | meta-analysis of percutaneous vs. surgical approaches radiofrequency ablation in hepatocellular carcinoma |
topic | Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763842/ https://www.ncbi.nlm.nih.gov/pubmed/35059430 http://dx.doi.org/10.3389/fsurg.2021.788771 |
work_keys_str_mv | AT huangxiaozhun metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma AT liuyibin metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma AT xulin metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma AT mateng metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma AT yinxin metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma AT huangzhangkan metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma AT wangcaibin metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma AT huangzhen metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma AT bixinyu metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma AT chexu metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma |